166438-70-6 Usage
Chemical Class
Piperazine derivatives
Mechanism of Action
Selective serotonin reuptake inhibitor (SSRI)
Potential Use
Treatment of depression and other mood disorders
Mode of Action
Increases levels of serotonin in the brain
Expected Benefit
Alleviation of depression symptoms
Side Effects
May have fewer side effects compared to other SSRIs
Current Status
Promising results in preclinical studies
Future Research
Further research needed to understand pharmacological properties and therapeutic applications
Check Digit Verification of cas no
The CAS Registry Mumber 166438-70-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,6,4,3 and 8 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 166438-70:
(8*1)+(7*6)+(6*6)+(5*4)+(4*3)+(3*8)+(2*7)+(1*0)=156
156 % 10 = 6
So 166438-70-6 is a valid CAS Registry Number.
166438-70-6Relevant articles and documents
ADENOSINE RECEPTOR BINDING COMPOUNDS
-
Paragraph 00325; 00344, (2020/02/06)
The present invention relates to pharmaceutical compounds and compositions of Formula (I) and methods of treatment using the compounds and compositions, especially for the treatment and/or prevention of a proliferation disorder, such as cancer. Compounds of Formula (I) as further described herein are shown modulators of the adenosine A2A receptor and exhibit antiproliferative activity. Accordingly, these compounds are useful to treat proliferative disorders such as cancer, and other adenosine receptor-related conditions including an inflammatory disease, renal disease, diabetes, vascular disease, lung disease, or an autoimmune disease.
